Replies to post #730582 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Femike do you see any light at the end of the tunnel? How do you see NWBOs market cap structural improving and when do you think this will happen?

Of course, that’s why I’m still invested. I just think it’s a longer and more challenging road, courtesy of Linda Powerless.

I think that -L getting approved will bolster the price enough to avoid a reverse split while Direct and combos get fleshed out.

I think we’ve got MHRA approval, Direct, and combo updates as the three big ticket items before another 3-4 year long doldrum. I’m hoping those three items (MM lawsuit is a wild card) can support the price in the $2-$4 range during that long multi year stretch of little development. Then it’ll be game on.

I’m gonna get bashed for this but I don’t think DCVax-L in its current form will ever be submitted to the FDA so that’s off the table for me. The company’s absolute refusal to speak to any plans for a BLA is in my opinion evidence that they have no plans to submit a BLA for DCVax-L as is.